MedPath

SHANTHA BIOTECHNICS PRIVATE LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers

Phase 1
Completed
Conditions
Rotavirus Gastroenteritis
Interventions
Biological: Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine (BRV-TV)
Other: Placebo
First Posted Date
2010-03-24
Last Posted Date
2011-06-08
Lead Sponsor
Shantha Biotechnics Limited
Target Recruit Count
20
Registration Number
NCT01091298
Locations
🇮🇳

Christian Medical College, Vellore, TamilNadu, India

Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine

Phase 1
Conditions
Rotavirus Gastroenteritis
Interventions
Biological: Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine
Other: Placebo
First Posted Date
2010-02-03
Last Posted Date
2010-10-04
Lead Sponsor
Shantha Biotechnics Limited
Target Recruit Count
90
Registration Number
NCT01061658
Locations
🇮🇳

Christian Medical College, Vellore, Tamilnadu, India

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

Phase 4
Conditions
Diphtheria
Tetanus
Pertussis
Hepatitis B
Haemophilus Influenzae Type B
Interventions
Biological: Shan 5
First Posted Date
2009-04-07
Last Posted Date
2009-05-06
Lead Sponsor
Shantha Biotechnics Limited
Target Recruit Count
3000
Registration Number
NCT00877357
Locations
🇮🇳

School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, UT, India

Safety and Efficacy Trial of Recombinant Human Granulocyte Colony Stimulating Factor (GCSF)

Phase 3
Completed
Conditions
Chemotherapy-Induced Neutropenia
Interventions
Biological: Recombinant Human GCSF (Shantha Biotechnics Limited)
Biological: Neupogen
First Posted Date
2008-10-21
Last Posted Date
2010-02-03
Lead Sponsor
Shantha Biotechnics Limited
Target Recruit Count
126
Registration Number
NCT00776165
Locations
🇮🇳

Seth Ramdas Shah Memorial Hospital, Pune, Maharashtra, India

🇮🇳

Vedanta Institute of Medical Sciences, Ahmedabad, Gujrat, India

🇮🇳

Regional Cancer Centre, Trivandrum, Kerala, India

and more 4 locations

Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants

Phase 1
Withdrawn
Conditions
Rotavirus Infections
Interventions
Biological: Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV]
Other: Placebo
First Posted Date
2008-09-23
Last Posted Date
2010-02-03
Lead Sponsor
Shantha Biotechnics Limited
Target Recruit Count
240
Registration Number
NCT00757926
Locations
🇮🇳

Christian Medical College, Vellore, Tamil Nadu, India

Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine

Phase 4
Completed
Conditions
Diphtheria
Tetanus
Pertussis
Hepatitis B
Haemophilus Influenzae Type B
Interventions
Biological: Shan 5
Biological: Easy Five
First Posted Date
2008-05-08
Last Posted Date
2009-06-25
Lead Sponsor
Shantha Biotechnics Limited
Target Recruit Count
144
Registration Number
NCT00674908
Locations
🇮🇳

Smt NHL Municipal Medical College and LG Hospital, Ahmedabad, Gujrat, India

🇮🇳

Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India

🇮🇳

Deenanath Mangeshkar Hospital, Pune, Maharashtra, India

Safety and Immunogenicity Study of a Liquid Pentavalent Combination Vaccine

Phase 4
Completed
Conditions
Diphtheria
Tetanus
Pertussis
Hepatitis B
Haemophilus Influenzae Type B
Interventions
Biological: Shan5
First Posted Date
2008-02-18
Last Posted Date
2009-06-25
Lead Sponsor
Shantha Biotechnics Limited
Target Recruit Count
160
Registration Number
NCT00617812
Locations
🇮🇳

Institute of Child Health, Kolkata, West Bengal, India

🇮🇳

Deccan College of Medical Sciences, Hyderabaad, Andhra Pradesh, India

🇮🇳

Ankur Institute of Child Health, Ahmedabad, Gujrat, India

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath